Clinical trials: Stage IV Pancreatic Cancer AJCC v6 and v7

Pancreatic Adenocarcinoma, Unresectable Pancreatic Carcinoma

Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery

• Active, not recruiting
• Age: 18 years and older
• Phase 1

This pilot phase I trial studies the side effects of gemcitabine hydrochloride, nab-paclitaxel, metformin hydrochloride, and a standardized dietary supplement in treating patients with pancreatic cancer that cannot be removed by…

Conditions

Pancreatic Adenocarcinoma, Unresectable Pancreatic Carcinoma, Stage III Pancreatic Cancer AJCC v6 and v7, Stage IV Pancreatic Cancer AJCC v6 and v7

Trial name

NCT02336087

Testing

Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride

Where

4 sites in United States

Volunteers

21 people

Sponsor

City of Hope Medical Center